Clinical Trials Logo

Radial Artery Injury clinical trials

View clinical trials related to Radial Artery Injury.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04439513 Recruiting - Clinical trials for Radial Artery Injury

Dual Artery Compression vs. Radial Artery-Only Hemostasis: Impact on Radial Artery Occlusion (EASY-RAO)

EASY-RAO
Start date: June 18, 2020
Phase: N/A
Study type: Interventional

This study aims to demonstrate the superiority in clinical performances of a dual artery compression device (Terry-2 band) compared to a standard radial artery-only hemostasis device (HemoSTOP).

NCT ID: NCT03889470 Recruiting - Clinical trials for Radial Artery Injury

Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center

NORAS
Start date: March 31, 2018
Phase: Phase 4
Study type: Interventional

The investigators will investigate whether administration of Nitroglycerin (NTG) as spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in patients undergoing transradial catheterization in radial center.

NCT ID: NCT03558243 Recruiting - Complication Clinical Trials

Prevention of Radial Artery Occlusion: Comparison of Three HEmostatiC Methods in Transradial Intervention

PROTHECT
Start date: May 1, 2018
Phase: N/A
Study type: Interventional

This study evaluates three hemostatic methods for prevention of radial artery occlusion. One third of patients will receive patent hemostasis, another third will receive patent hemostasis plus ulnar compression and the last third will receive the StatSeal hemostatic disc.

NCT ID: NCT02982733 Recruiting - Hematoma Clinical Trials

Ankaferd Blood Stopper for Hemostasis After Transradial Coronary Angiography

Start date: November 2016
Phase: N/A
Study type: Interventional

In 2008 Goker et al, introduced Ankaferd Blood Stopper (ABS) as a new hemostatic drug. Recently, ABS has been shown to produce local hemostasis by implementing topically after major arterial vessel injury. Reducing the compression time during patent hemostasis by facilitating hemostasis may decrease RAO. To test this hypothesis the investigators planned a three arm randomized study to evaluate the safety and efficacy of Ankaferd blood stopper in adjunct to short-time compression, compared to either short-time compression with conventional sterile gauzes or with a TR band after transradial diagnostic procedures.